NYR Stock Discussion
Nyrada Inc. Description
Nyrada Inc (NYR) is a preclinical stage, drug development company. The Company specialises in the development of novel small molecule drugs pertaining to the underlying pathological processes involved in cardiovascular, neurodegenerative and chronic inflammatory diseases. It focuses on areas of substantial unmet clinical need and has identified drug candidates with therapeutic and commercial potential, where few if any, effective or well-tolerated therapies exist. It currently has three wholly-owned drug programs:
Industry: Biotechnology
Keywords: Disease Diseases Drugs Drug Development
Recent Comments
- SwingTradeBot on Market Recap for Wednesday, February 28, 2024
- SwingTradeBot on Market Recap for Tuesday, February 27, 2024
- SwingTradeBot on Market Recap for Monday, February 26, 2024
- SwingTradeBot on Market Recap for Friday, February 23, 2024
- SwingTradeBot on Market Recap for Thursday, February 22, 2024
From the Blog
Featured Articles